OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 inhibitors for patients with type 2 diabetes mellitus after myocardial infarction: a nationwide observation registry study from SWEDEHEART
H C Rosen, Moman A. Mohammad, Tomas Jernberg, et al.
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101032-101032
Open Access | Times Cited: 7
H C Rosen, Moman A. Mohammad, Tomas Jernberg, et al.
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101032-101032
Open Access | Times Cited: 7
Showing 7 citing articles:
Diagnosis and management of type 2 diabetes mellitus in patients with ischaemic heart disease and acute coronary syndromes - a review of evidence and recommendations
Muhammad Usman Shah, Alun Roebuck, Bala Srinivasan, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 4
Muhammad Usman Shah, Alun Roebuck, Bala Srinivasan, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 4
Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
Michele Maremmani, Ramin Ebrahimi, Marco Centola, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Michele Maremmani, Ramin Ebrahimi, Marco Centola, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Possibilities of Optimizing Drug Therapy for Myocardial Infarction: a Consensus on the Use of Type 2 Sodium-Glucose Co-Transporter Inhibitors. Conciliation Document of the Expert Group
G. P. Arutyunov, С. К. Кононов, N Novitskii, et al.
Kardiologiia (2025) Vol. 65, Iss. 3, pp. 35-47
Closed Access
G. P. Arutyunov, С. К. Кононов, N Novitskii, et al.
Kardiologiia (2025) Vol. 65, Iss. 3, pp. 35-47
Closed Access
The cardio‐renal‐metabolic role of the nod‐like receptor protein‐3 and senescence‐associated secretory phenotype in early sodium/glucose cotransporter‐2 inhibitor therapy in people with diabetes who have had a myocardial infarction
Muhammad Usman Shah, Chelsy L. Cliff, Paul E. Squires, et al.
Diabetic Medicine (2025)
Open Access
Muhammad Usman Shah, Chelsy L. Cliff, Paul E. Squires, et al.
Diabetic Medicine (2025)
Open Access
Expanding the Use of SGLT2 Inhibitors in T2D Patients Across Clinical Settings
Alessandro Cuttone, Vittorio Cannavò, Rana Abdullah, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 668-668
Open Access
Alessandro Cuttone, Vittorio Cannavò, Rana Abdullah, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 668-668
Open Access
Failure to improve cardiac remodelling and outcomes post‐myocardial infarction: Insights from EMPRESS ‐MI
Francesco Fioretti, Gregg W. Stone, Javed Butler
European Journal of Heart Failure (2025)
Open Access
Francesco Fioretti, Gregg W. Stone, Javed Butler
European Journal of Heart Failure (2025)
Open Access
Predicting the impact of stress-induced hyperglycemia on in-hospital mortality in patients with chronic kidney disease and acute coronary syndrome: A retrospective study
Yike Li, Nan Shen, Enmin Xie, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 12, pp. 108895-108895
Closed Access | Times Cited: 1
Yike Li, Nan Shen, Enmin Xie, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 12, pp. 108895-108895
Closed Access | Times Cited: 1
Emerging data on SGLT2 benefits in acute coronary syndromes
Aidin Rawshani
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101085-101085
Open Access
Aidin Rawshani
The Lancet Regional Health - Europe (2024) Vol. 45, pp. 101085-101085
Open Access
